Compare Colgate-Palmolive Company (CL) vs Oklo Inc (OKLO) Price & Performance

Colgate-Palmolive (CL) trades at $93.27, up 0.29% on the day, with a bullish technical signal and consistent earnings beats. The company reported Q2 2026 EPS of $0.99, exceeding estimates, driven by strong margins and organic growth in emerging markets, though North American performance remains weak. Operating cash flow remains robust at $4.2 billion in 2025, supporting shareholder returns.

Outlook is mixed: valuation appears stretched with a P/E of 36.72, but analyst consensus targets $99.10. Risks include competitive pressures in North America and high debt levels. The stock offers a stable dividend, but growth concerns and insider selling warrant caution.

OKLO trades at $48.42, up 14.77% in the past 24 hours, with a bullish technical signal and strong analyst consensus. The stock is supported by recent milestones, including the Groves reactor achieving first criticality and reporting its first meaningful revenue of $1.2 million in Q2 2026, though it posted a wider net loss. The company maintains substantial liquidity of approximately $2.5 billion as of March 2026, supporting its aggressive development plans.

The outlook is optimistic due to strong institutional backing and growth potential in the nuclear energy sector, but significant execution risks and persistent losses pose challenges. The consensus price target of $82.69 suggests substantial upside if operational milestones are met, yet the high cash burn and unproven business model warrant caution for investors.